Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 … T Masuda, H Inoue, H Sonoda, S Mine, Y Yoshikawa, K Nakayama, ... Cancer research 62 (13), 3819-3825, 2002 | 345 | 2002 |
Advantages of totally laparoscopic distal gastrectomy over laparoscopically assisted distal gastrectomy for gastric cancer O Ikeda, Y Sakaguchi, Y Aoki, N Harimoto, J Taomoto, T Masuda, T Ohga, ... Surgical endoscopy 23, 2374-2379, 2009 | 184 | 2009 |
Clinical and biological significance of circulating tumor cells in cancer T Masuda, N Hayashi, T Iguchi, S Ito, H Eguchi, K Mimori Molecular oncology 10 (3), 408-417, 2016 | 157 | 2016 |
Circulating exosomal microRNA-203 is associated with metastasis possibly via inducing tumor-associated macrophages in colorectal cancer Y Takano, T Masuda, H Iinuma, R Yamaguchi, K Sato, T Tobo, H Hirata, ... Oncotarget 8 (45), 78598, 2017 | 155 | 2017 |
Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma T Masuda, H Inoue, K Nishida, H Sonoda, Y Yoshikawa, Y Kakeji, ... Clinical cancer research 9 (15), 5693-5698, 2003 | 144 | 2003 |
Decreased expression of fructose-1, 6-bisphosphatase associates with glucose metabolism and tumor progression in hepatocellular carcinoma H Hirata, K Sugimachi, H Komatsu, M Ueda, T Masuda, R Uchi, ... Cancer research 76 (11), 3265-3276, 2016 | 130 | 2016 |
Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer K Mimori, Y Tanaka, K Yoshinaga, T Masuda, K Yamashita, M Okamoto, ... Annals of oncology 15 (2), 236-241, 2004 | 117 | 2004 |
MicroRNAs as biomarkers in colorectal cancer T Masuda, N Hayashi, Y Kuroda, S Ito, H Eguchi, K Mimori Cancers 9 (9), 124, 2017 | 112 | 2017 |
A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer T Saito, A Niida, R Uchi, H Hirata, H Komatsu, S Sakimura, S Hayashi, ... Nature communications 9 (1), 2884, 2018 | 106 | 2018 |
MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway K Mimori, T Shiraishi, K Mashino, H Sonoda, K Yamashita, K Yoshinaga, ... Oncogene 22 (22), 3463-3471, 2003 | 100 | 2003 |
Significance of skp2 expression in primary breast cancer. H Sonoda, H Inoue, K Ogawa, T Utsunomiya, T Masuda, M Mori Clinical cancer research: an official journal of the American Association …, 2006 | 86 | 2006 |
N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma K Yoshinaga, H Inoue, T Utsunomiya, H Sonoda, T Masuda, K Mimori, ... Clinical cancer research 10 (17), 5702-5707, 2004 | 80 | 2004 |
Absence of Msh2 protein expression is associated with alteration in the FHIT locus and Fhit protein expression in colorectal carcinoma M Mori, K Mimori, T Masuda, K Yoshinaga, K Yamashita, A Matsuyama, ... Cancer research 61 (20), 7379-7382, 2001 | 72 | 2001 |
New technique for the retraction of the liver in laparoscopic gastrectomy Y Sakaguchi, O Ikeda, Y Toh, Y Aoki, N Harimoto, J Taomoto, T Masuda, ... Surgical endoscopy 22, 2532-2534, 2008 | 69 | 2008 |
Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence M Ueda, T Iguchi, T Masuda, Y Nakahara, H Hirata, R Uchi, A Niida, ... Oncotarget 7 (38), 62280, 2016 | 68 | 2016 |
BRCA1 deficiency impairs mitophagy and promotes inflammasome activation and mammary tumor metastasis Q Chen, JH Lei, J Bao, H Wang, W Hao, L Li, C Peng, T Masuda, K Miao, ... Advanced Science 7 (6), 1903616, 2020 | 59 | 2020 |
Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients TA Masuda, A Kataoka, S Ohno, S Murakami, K Mimori, T Utsunomiya, ... International journal of oncology 26 (3), 721-730, 2005 | 56 | 2005 |
Clinical characteristics of gastric cancer with metastasis to the lymph node along the superior mesenteric vein (14v) T Masuda, Y Sakaguchi, Y Toh, Y Aoki, N Harimoto, J Taomoto, O Ikeda, ... Digestive surgery 25 (5), 351-358, 2008 | 52 | 2008 |
Phase I dose‐escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer T Masuda, M Noda, T Kogawa, D Kitagawa, N Hayashi, T Jomori, ... Cancer Science 111 (3), 924-931, 2020 | 51 | 2020 |
Oncogenic splicing abnormalities induced by DEAD‐Box Helicase 56 amplification in colorectal cancer Y Kouyama, T Masuda, A Fujii, Y Ogawa, K Sato, T Tobo, H Wakiyama, ... Cancer science 110 (10), 3132-3144, 2019 | 51 | 2019 |